{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-015938","form_type":"8-K","ticker":"ZVSA","cik":"0001859007","company_name":"ZyVersa Therapeutics, Inc.","filed_at":"2024-04-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.936494+00:00","generated_at":"2026-06-03T08:14:26.529758+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ZyVersa Therapeutics executes 1-for-10 reverse stock split effective April 25, 2024","bullets":["Reverse split ratio 1-for-10; approved by stockholders at special meeting on April 17, 2024.","Effective at 4:01 p.m. ET on April 25; split-adjusted trading begins April 26 on Nasdaq.","Par value unchanged; new CUSIP number is 98987D 300.","Common stock continues trading under symbol ZVSA on Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-015938","json":"https://secwatch.observer/filing/0001493152-24-015938.json","markdown":"https://secwatch.observer/filing/0001493152-24-015938.md","text":"https://secwatch.observer/filing/0001493152-24-015938.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859007/000149315224015938/0001493152-24-015938-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859007/000149315224015938/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T08:14:26.529758+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"78a52c53127d182bca9fc736f46f723937b07cad","claim":"ZyVersa Therapeutics, Inc.: Filed a certificate of amendment to effect a 1-for-10 reverse stock split of common stock (effective 2024-04-25).","evidence_excerpt":"On April 25, 2024, ZyVersa Therapeutics, Inc. (the \"Company\") filed a certificate of amendment to the Company’s Second Amended and Restated Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware relating to a 1-for-10 reverse stock split (the “Reverse Stock Split”) of the outstanding shares of the Company’s common stock (“Common Stock”). The Reverse Stock Split became effective on April 25, 2024 at 4:01 p.m., and the Common Stock is expected to begin trading on The Nasdaq Capital Market on a Reverse Stock Split-adjusted basis on April 26, 2024 at market open.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1859007/000149315224015938/0001493152-24-015938-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-04-25"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}